Association of common variants in NPPA and NPPB with blood pressure does not translate into kidney damage in a general population study

Journal of Hypertension

Volumn 28, Issue 6, 2010, Pages 1230-1233

  Maimaitiming, Suliya ^a   Roussel, Ronan ^a,b,c   Hadjadj, Samy ^a,d   Fumeron, Frédéric ^a,b   Aubert, Roberte ^a   Emery, Nathalie ^a,b   Velho, Gilberto ^a   Mohammedi, Kamel ^a,b,c   Travert, Florence ^a,b,c   Tichet, Jean ^e   Alhenc Gelas, Francois ^f   Balkau, Beverley ^a,g   Marre, Michel ^a,b,c  

^a INSERM   (France)

^b University Denis Diderot   (France)

^c BICHAT HOSPITAL   (France)

^d POITIERS UNIVERSITY HOSPITAL   (France)

^e IRSA   (France)

^f CENTRE DE RECHERCHE DES CORDELIERS   (France)

^g UNIVERSITÉ PARIS SACLAY   (France)

Author keywords

Atrial natriuretic peptide; Blood pressure; Brain natriuretic peptide; Polymorphisms

Indexed keywords

ALBUMIN; ATRIAL NATRIURETIC FACTOR; BRAIN NATRIURETIC PEPTIDE; CREATININE; CYTOSINE; GENOMIC DNA; GUANINE; INSULIN;

ADULT; ALLELE; ARTICLE; BLOOD LEVEL; BODY MASS; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DNA EXTRACTION; EPIDEMIOLOGICAL DATA; FEMALE; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC VARIABILITY; GLOMERULUS FILTRATION RATE; HAPLOTYPE; HUMAN; HYPERTENSION; INSULIN RESISTANCE; KIDNEY INJURY; MAJOR CLINICAL STUDY; MALE; MICROALBUMINURIA; OUTCOME ASSESSMENT; PATHOGENESIS; PRIORITY JOURNAL; PROGNOSIS; SYSTOLIC BLOOD PRESSURE;

EID: 77952543304     PISSN: 02636352     EISSN: None     Source Type: Journal    
DOI: 10.1097/HJH.0b013e328338a901     Document Type: Article

References (11)

1. Atkins RC. The epidemiology of chronic kidney disease. Kidney Int. 2005; 94(Suppl.):S14-S18.
2. Tobin MD, Raleigh SM, Newhouse S, Braund P, Bodycote C, Ogleby J, et al. Association of WNK1 gene polymorphisms and haplotypes with ambulatory blood pressure in the general population. Circulation 2005; 112:3423-3429.
3. Newton-Cheh C, Larson MG, Vasan RS, Levy D, Bloch KD, Surti A, et al. Association of common variants in NPPA and NPPB with circulating natriuretic peptides and blood pressure. Nat Genet 2009; 41:348-353.
4. Balkau B. An epidemiologic survey from a network of French Health Examination Centres, (D.E.S.I.R.): epidemiologic data on the insulin resistance syndrome. Rev Epidemiol Sante Publique 1996; 44:373-375.
5. O'Brien E, Mee F, Atkins N, Thomas M. Evaluation of three devices for self-measurement of blood pressure according to the revised British Hypertension Society Protocol: the Omron HEM-705CP, Philips HP5332, and Nissei DS-175. Blood Press Monit 1996; 1:55-81.
6. Levey AS, Bosch JP, Lewis JB, Groehe T, Rogers N, Roth D. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study group. Ann Intern Med 1999; 130:461-470.
7. Tregouet D, Tiret L. Cox proportional hazards survival regression in haplotype-based association analysis using the Stochastic-EM algorithm. Eur J Hum Genet 2004; 12:971-974.
8. Menashe I, Rosenberg PS, Chen BE. PGA: power calculator for case-control genetic association analyses. BMC Genet 2008; 9:36.
9. Pereira TV, Rudnicki M, Cheung BM, Baum L, Yamada Y, Oliveira PS, et al. Three endothelial nitric oxide (NOS3) gene polymorphisms in hypertensive and normotensive individuals: meta-analysis of 53 studies reveals evidence of publication bias. J Hypertens 2007; 25:1763-1774.
10. Roussel R, Tregouet DA, Hadjadj S, Jeunemaitre X, Marre M. Investigation of the human ANP gene in type 1 diabetic nephropathy: case-control and follow-up studies. Diabetes 2004; 53:1394-1398.
11. Lynch AI, Boerwinkle E, Davis BR, Ford CE, Eckfeldt JH, Leiendecker-FosterC,et al. Pharmacogeneticassociationof the NPPA T2238C genetic variant with cardiovascular disease outcomes in patients with hypertension. JAMA 2008; 299:296-307.